The term demyelination refers to the loss of the myelin sheath that surrounds and protects axons in the central nervous system. Demyelination occurs as the result of diseases that damage the myelin ...

This page lists all known medications that could potentially lead to 'Osmotic demyelination syndrome' as a side effect. It's important to note that mild side effects are quite common with medications.

Transcriptomics of two prevailing models, cuprizone (CPZ) and lysophosphatidylcholine (LPC), reveal understanding of myelin loss and regeneration.

Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common chronic immune-mediated neuropathy. It affects peripheral nerves and roots. CIDP has no biomarkers. It may be monophasic or ...

Findings from a retrospective study comparing typical and myelocortical multiple sclerosis (MS) identified major pathological differences between the 2 MS subtypes and determined that demyelination ...

A new study compares CPZ and LPC models, creating a genetic roadmap to accelerate myelin regeneration therapies for Multiple ...

Pembrolizumab and nivolumab, two humanized antibodies against programmed cell death 1 (PD-1) receptor, were recently approved for the treatment of unresectable or metastatic melanoma and for other ...

Stock Gains After Enrollment Milestone Reached Shares of Quantum BioPharma (NASDAQ:QNTM) rose 10% in premarket trading on ...

Demyelination occurs when the protective covering of nerve fibers in the brain, spinal cord, and optic nerves, known as myelin, is damaged. This myelin sheath facilitates the rapid transmission of ...

Classic chronic inflammatory demyelinating polyneuropathy is characterized by the occurrence of symmetrical weakness in both proximal and distal muscles that progressively increases for more than two ...